These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17000251)

  • 1. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey.
    Ness A; Dias T; Damus K; Burd I; Berghella V
    Am J Obstet Gynecol; 2006 Oct; 195(4):1174-9. PubMed ID: 17000251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States.
    Ness A; Baxter J; Hyslop T; Berghella V
    J Reprod Med; 2006 May; 51(5):411-5. PubMed ID: 16779989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and practices regarding use of progesterone to prevent preterm births.
    Henderson ZT; Power ML; Berghella V; Lackritz EM; Schulkin J
    Am J Perinatol; 2009 Aug; 26(7):529-36. PubMed ID: 19301227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From concept to practice: the recent history of preterm delivery prevention. Part II: Subclinical infection and hormonal effects.
    Vidaeff AC; Ramin SM
    Am J Perinatol; 2006 Feb; 23(2):75-84. PubMed ID: 16506112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestational agents for the prevention of preterm birth.
    Lamont RF; Jayasooriya GS
    J Perinat Med; 2009; 37(1):12-4. PubMed ID: 18999914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of progesterone to prevent preterm birth at a tertiary care center.
    Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM
    J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies.
    O'Brien JM; Lewis DF
    J Reprod Med; 2009 Feb; 54(2):73-87. PubMed ID: 19301570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary practice patterns and beliefs regarding tocolysis among u.s. Maternal-fetal medicine specialists.
    Fox NS; Gelber SE; Kalish RB; Chasen ST
    Obstet Gynecol; 2008 Jul; 112(1):42-7. PubMed ID: 18591306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Alabama Preterm Birth Project: placental histology in recurrent spontaneous and indicated preterm birth.
    Goldenberg RL; Andrews WW; Faye-Petersen O; Cliver S; Goepfert AR; Hauth JC
    Am J Obstet Gynecol; 2006 Sep; 195(3):792-6. PubMed ID: 16846583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetrician-gynecologists' screening and management of preterm birth.
    Morgan MA; Goldenberg RL; Schulkin J
    Obstet Gynecol; 2008 Jul; 112(1):35-41. PubMed ID: 18591305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of progesterone treatment for the prevention of recurrent preterm birth: identification of obstacles to change.
    Lim AC; Goossens A; Ravelli AC; Boer K; Bruinse HW; Mol BW
    Am J Perinatol; 2010 Mar; 27(3):241-9. PubMed ID: 19823963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and prevention of recurrent spontaneous preterm birth.
    Spong CY
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):405-15. PubMed ID: 17666618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal progesterone to prevent preterm birth in high-risk women.
    Fontenot HB; Fantasia HC
    Nurs Womens Health; 2012; 16(3):237-41. PubMed ID: 22697227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients.
    Berti D; Moons P; Dobbels F; Deuson R; Janssens A; De Geest S
    Clin Ther; 2008 Aug; 30(8):1540-52. PubMed ID: 18803995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth.
    Calda P
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):540-2. PubMed ID: 19089768
    [No Abstract]   [Full Text] [Related]  

  • 20. Antenatal progesterone to prevent preterm birth.
    Doyle LW
    Lancet; 2009 Jun; 373(9680):2000-2. PubMed ID: 19523682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.